socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Wednesday, May 28, 2008

    Abraxis BioScience Names CFO
    Los Angeles-based Abraxis BioScience said today that it has named David O'Toole as the firm's Executive Vice President and Chief Financial Officer. O'Toole joins the firm from Deloitte & Touche LLP, where he was a Partner in the firm's Strategic Client Group. O'Toole has served at Deloitte for the past 16 years. Abraxis said that it's current CFO, Lisa Gopala, has resigned to join a philanthropic venture fund. Abraxis BioScience is a biopharmaceuticals development firm.
    posted on Wednesday, May 28, 2008

    Related stories:
    > Abraxis BioScience Spins off From APP Pharmaceuticals
    > Abraxis BioScience Acquires Two Biotech Firms
    > Abraxis Bioscience Buys Manufacturing Complex From Pfizer
    > Illumina Names CTO
    > Prolacta Bioscience Raises $12M

    RSS Feed
    subscri be via emailNewsletter


    Previous news:

     Thursday, August 28, 2008
    Wednesday, August 27, 2008
    Tuesday, August 26, 2008
    Monday, August 25, 2008
    Friday, August 22, 2008